Cognex Corporation $CGNX Holdings Decreased by Alyeska Investment Group L.P.

Key Points

• Alyeska Investment Group cut its Cognex stake by 47.3% in the second quarter, selling 520,345 shares and retaining 580,846 shares worth approximately $42.1 million. Institutional investors collectively own 88.12% of Cognex.
• Cognex reported quarterly EPS of $0.45, exceeding analyst expectations of $0.42, while revenue rose 16.9% year over year to $291.26 million. The company provided fiscal 2026 EPS guidance of $1.64–$1.68.
• The stock opened at $60.46, below the analyst consensus price target of $75.64, while analysts maintain a consensus “Moderate Buy” rating. Cognex also declared a quarterly dividend of $0.085 per share, representing a 0.6% annualized yield.

Alyeska Investment Group L.P. cut its position in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 47.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 580,846 shares of the scientific and technical instruments company's stock after selling 520,345 shares during the quarter. Alyeska Investment Group L.P. owned 0.35% of Cognex worth $42,065,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in CGNX. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Cognex during the 2nd quarter valued at about $26,000. Geneos Wealth Management Inc. grew its holdings in Cognex by 402.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock worth $27,000 after buying an additional 736 shares in the last quarter. Rakuten Securities Inc. bought a new position in Cognex in the 2nd quarter worth approximately $32,000. Transamerica Financial Advisors LLC acquired a new stake in Cognex in the 2nd quarter valued at approximately $32,000. Finally, Elevation Wealth Partners LLC raised its stake in Cognex by 635.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 478 shares of the scientific and technical instruments company's stock valued at $35,000 after acquiring an additional 413 shares in the last quarter. Institutional investors own 88.12% of the company's stock.

Cognex Price Performance

Shares of NASDAQ CGNX opened at $60.46 on Monday. Cognex Corporation has a 12 month low of $34.60 and a 12 month high of $72.88. The company has a market cap of $10.17 billion, a price-to-earnings ratio of 58.70 and a beta of 1.49. The business has a fifty day simple moving average of $64.43 and a 200-day simple moving average of $59.57.

Cognex (NASDAQ:CGNX - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping analysts' consensus estimates of $0.42 by $0.03. The firm had revenue of $291.26 million for the quarter, compared to analysts' expectations of $292.10 million. Cognex had a return on equity of 13.50% and a net margin of 16.05%.Cognex's revenue was up 16.9% on a year-over-year basis. During the same quarter last year, the business posted $0.25 EPS. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, sell-side analysts expect that Cognex Corporation will post 1.68 EPS for the current fiscal year.

Cognex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Thursday, August 20th will be paid a $0.085 dividend. The ex-dividend date of this dividend is Thursday, August 20th. This represents a $0.34 dividend on an annualized basis and a yield of 0.6%. Cognex's dividend payout ratio (DPR) is currently 33.01%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Zacks Research upgraded shares of Cognex from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, June 16th. Truist Financial increased their target price on shares of Cognex from $71.00 to $78.00 and gave the company a "hold" rating in a research report on Friday, August 7th. Sanford C. Bernstein restated an "outperform" rating and set a $75.00 price target on shares of Cognex in a research report on Thursday, May 7th. Wall Street Zen lowered shares of Cognex from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Finally, UBS Group set a $75.00 price objective on shares of Cognex in a report on Tuesday, May 26th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $75.64.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source